KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Capital Leases: 2010-2011

  • Ionis Pharmaceuticals' Capital Leases fell 15.14% to $656,000 in Q4 2011 from the same period last year, while for Dec 2011 it was $656,000, marking a year-over-year decrease of 15.14%. This contributed to the annual value of $656,000 for FY2011, which is 15.14% down from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Capital Leases of $656,000 as of Q4 2011, which was down 15.14% from $773,000 recorded in Q4 2010.
  • Ionis Pharmaceuticals' Capital Leases' 5-year high stood at $773,000 during Q4 2010, with a 5-year trough of $656,000 in Q4 2011.
  • Its 2-year average for Capital Leases is $714,500, with a median of $714,500 in 2010.
  • Data for Ionis Pharmaceuticals' Capital Leases shows a maximum YoY decreased of 15.14% (in 2011) over the last 5 years.
  • Ionis Pharmaceuticals' Capital Leases (Quarterly) stood at $773,000 in 2010, then decreased by 15.14% to $656,000 in 2011.